Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC - Antonia, SJ; Villegas, A; Daniel, D; Vicente, D; Murakami, S; Hui, R; PACIFIC Investigators (N Engl J Med, 2018)
. Epub ahead of print